Toxicokinetics of inhaled trichloroethylene and tetrachloroethylene in humans at 1 ppm: Empirical results and comparisons with previous studies

Toxicological Sciences

Volumn 95, Issue 1, 2007, Pages 23-36

  Chiu, Weihsueh A ^a   Micallef, Sandrine ^b   Monster, Aart C ^c   Bois, Frédéric Y ^b  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b INSTITUT NATIONAL DE L ENVIRONNEMENT INDUSTRIEL ET DES RISQUES INERIS   (France)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Bio transformation and toxico kinetics; Dosimetry; Pharmacokinetics toxicokinetics; Risk assessment; Volatile organic compounds

Indexed keywords

GLUCURONIC ACID; TETRACHLOROETHYLENE; TRICHLOROACETIC ACID; TRICHLOROETHANOL; TRICHLOROETHYLENE;

ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; BREATH ANALYSIS; CLEARANCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; EMPIRICISM; ENVIRONMENTAL EXPOSURE; EXHALATION; GLUCURONIDATION; HUMAN; HUMAN EXPERIMENT; INHALATION; LUNG ALVEOLUS; MALE; NORMAL HUMAN; PARTITION COEFFICIENT; TOXICOKINETICS; TOXICOLOGICAL PARAMETERS; UNCERTAINTY; URINE LEVEL;

AIR POLLUTANTS; ANALYSIS OF VARIANCE; AREA UNDER CURVE; BIOTRANSFORMATION; BREATH TESTS; HUMANS; INHALATION EXPOSURE; MALE; METABOLIC CLEARANCE RATE; MODELS, BIOLOGICAL; PULMONARY ALVEOLI; REFERENCE VALUES; SOLVENTS; TETRACHLOROETHYLENE; TRICHLOROETHYLENE;

EID: 33845674209     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfl129     Document Type: Article

References (48)

1. Anders, M. W., Lash, L., Dekant, W., Elfarra, A. A., and Dohn, D. R. (1988). Biosynthesis and biotransformation of glutathione S-conjugates to toxic metabolites. Crit. Rev. Toxicol. 18(4), 311-341.
2. Åstrand, I. (1983). Effect of physical exercise on uptake, distribution and elimination of vapors in man. In Modeling of Inhalation Exposure to Vapors: Uptake, Distribution, and Elimination (F. Fiserova-Bergerova, Ed.), pp. 107-130. CRC Press, Boca Raton, FL.
3. ATSDR (Agency for Toxic Substances and Disease Registry). (1997a). Toxicological Profile for Tetrachloroethylene (Update). U.S. Department of Health and Human Services, Atlanta.
4. ATSDR. (1997b). Toxicological Profile for Trichloroethylene (Update). U.S. Department of Health and Human Services, Atlanta.
5. Bartonicek, V. (1962). Metabolism and excretion of trichloroethylene after inhalation by human subjects. Br J. Ind. Med. 19, 134-141.
6. Bernauer, U., Birner, G., Dekant, W., and Henschler, D. (1996). Biotransformation of trichloroethene: Dose-dependent excretion of 2,2,2-trichlorometabolites and mercapturic acids in rats and humans after inhalation. Arch. Toxicol. 70(6), 338-346.
7. Birner, G., Vamvakas, S., Dekant, W., and Henschler, D. (1993). Nephrotoxic and genotoxic N-acetyl-S-dichlorovinyl-L-cysteine is a urinary metabolite after occupational 1,1,2-trichloroethene exposure in humans: Implications for the risk of trichloroethene exposure. Environ. Health Perspect. 99, 281-284.
8. Bloemen, L. J., Monster, A. C., Kezic, S., Commandeur, J. N. M., Veulemans, H., Vermeulen, N. P. E., and Wilmer, J. W. (2001). Study on the cytochrome P-450-and glutathione-dependent biotransformation of trichloroethylene in humans. Int. Arch. Occup. Environ. Health 74(2), 102-108.
9. Bois, F. Y. (2000). Statistical analysis of Fisher et al. PBPK model of trichloroethylene kinetics. Environ. Health Perspect. 108(Suppl. 2), 275-282.
10. Bois, F. Y., Gelman, A., Jiang, J., Maszle, D., Zeise, L., and Alexeef, G. (1996). Population toxicokinetics of tetrachloroethylene. Arch. Toxicol. 70, 347-355.
11. Boyes, W. K., Evans, M. V., Eklund, C., Janssen, P., and Simmons, J. E. (2005). Duration adjustment of acute exposure guideline level values for trichloroethylene using a physiologically-based pharmacokinetic model. Risk Anal. 25(3), 677-686.
12. Bull, R. J. (2000). Mode of action of liver tumor induction by trichloroethylene and its metabolites, trichloroacetate and dichloroacetate. Environ. Health Perspect. 108(Suppl. 2), 241-259.
13. Cai, H. L., and Guengerich, F. P. (1999). Mechanisms of aqueous decomposition of trichloroethylene oxide. J. Am. Chem. Soc. 121, 11656-11663.
14. Caldwell, J. C., and Keshava, N. (2006). Key issues in the modes of action and effects of trichloroethylene metabolites for liver and kidney tumorigenesis. Environ. Health Perspect. 114(9), 1457-1463.
15. Chiu, W. A., and Bois, F. Y. (2006). Revisiting the population toxicokinetics of tetrachloroethylene. Arch. Toxicol. 80(6), 382-385.
16. Chiu, W. A., Okino, M. S., Lipscomb, J. C., and Evans, M. V. (2006). Issues in the pharmacokinetics of trichloroethylene and its metabolites. Environ. Health Perspect. 114(9), 1450-1456.
17. Christensen, J. M., Rasmussen, K., and Koppen, B. (1988). Automatic headspace gas chromatographic method for the simultaneous determination of trichloroethylene and metabolites in blood and urine. J. Chromatogr. 442, 317-323.
18. Clewell, H. J., Gentry, P. R., Covington, T. R., and Gearhart, J. M. (2000). Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment. Environ. Health Perspect. 108(Suppl. 2), 283-305.
19. Covington, T. R., Gentry, P. R., Van Landingham, C. B., Andersen, M. E., Kester, J. E., and Clewell, H. J. (2006). The use of Markov chain Monte Carlo uncertainty analysis to support a Public Health Goal for perchloroethylene. Regul. Toxicol. Pharmacol., doi:109.1016/ j.yrtph.2006.06.008.
20. Fiserova-Bergerova, V., Tichy, M., and Di Carlo, F. J. (1984). Effects of biosolubility on pulmonary uptake and disposition of gases and vapors of lipophilic chemicals. Drug Metab. Rev. 15, 1033-1070.
21. Fisher, J. W., Mahle, D., and Abbas, R. (1998). A human physiologically based pharmacokinetic model for trichloroethylene and its metabolites, trichloroacetic acid and free trichloroethanol. Toxicol. Appl. Pharmacol. 152(2), 339-359.
22. Gargas, M. L., Burgess, R. J., Voisard, D. E., Cason, G. H., and Andersen, M. E. (1989). Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues. Toxicol. Appl. Pharmacol. 98, 87-99.
23. Gearhart, J. M., Mahle, D. A., Greene, R. J., Seckel, C. S., Flemming, C. D., Fisher, J. W., and Clewell, H. J., III (1993). Variability of physiologically based pharmacokinetic (PBPK) model parameters and their effects on PBPK model predictions in a risk assessment for perchloroethylene (PCE). Toxicol. Lett. 68(1-2), 131-144.
24. Green, T. (2000). Pulmonary toxicity and carcinogenicity of trichloroethylene: Species differences and modes of action. Environ. Health Perspect. 108(Suppl. 2), 261-264.
25. Green, T., Dow, J., Ellis, M. K., Foster, J. R., and Odum, J. (1997). The role of glutathione conjugation in the development of kidney tumours in rats exposed to trichloroethylene. Chem Biol. Interact. 105(2), 99-117.
26. 1 mice. Toxicol. Appl. Pharmacol. 154, 264-278.
27. Kimmerle, G., and Eben, A. (1973). Metabolism, excretion and toxicology of trichloroethylene after inhalation. 2. Experimental human exposure. Arch. Toxikol. 30(2), 127-138.
28. Krause, R. J., Lash, L. H., and Elfarra, A. A. (2003). Human kidney flavin-containing monooxygenases and their potential roles in cysteine s-conjugate metabolism and nephrotoxicity. J. Pharmacol. Exp. Ther. 304(1), 185-191.
29. Laparé, S., Tardif, R., and Brodeur, J. (1995). Effect of various exposure scenarios on the biological monitoring of organic solvents in alveolar air - II. 1,1,1-Trichloroethane and trichloroethylene. Int. Arch. Occup. Environ. Health 67, 375-394.
30. Lash, L. H., Fisher, J. W., Lipscomb, J. C., and Parker, J. C. (2000a). Metabolism of trichloroethylene. Environ. Health Perspect. 108(Suppl. 2), 177-200.
31. Lash, L. H., Lipscomb, J. C., Putt, D. A., and Parker, J. C. (1999a). Glutathione conjugation of trichloroethylene in human liver and kidney: Kinetics and individual variation. Drug Metab. Dispos. 27(3), 351-359.
32. Lash, L. H., and Parker, J. C. (2001). Hepatic and renal toxicities associated with perchloroethylene. Pharmacol. Rev. 53(2), 177-208.
33. Lash, L. H., Parker, J. C., and Scott, C. S. (2000b). Modes of action of trichloroethylene for kidney tumorigenesis. Environ. Health Perspect. 108(Suppl. 2), 225-240.
34. Lash, L. H., Putt, D. A., Brashear, W. T., Abbas, R., Parker, J. C., and Fisher, J. W. (1999b). Identification of S-(1,2-dichlorovinyl)glutathione in the blood of human volunteers exposed to trichloroethylene. J. Toxicol. Environ. Health A 56(1), 1-21.
35. Lash, L. H., Putt, D. A., Hueni, S. E., Krause, R. J., and Elfarra, A. A. (2003). Roles of necrosis, apoptosis, and mitochondrial dysfunction in S-(1,2-dichlorovinyl)-L-cysteine sulfoxide-induced cytotoxicity in primary cultures of human renal proximal tubular cells. J. Pharmacol. Exp. Ther. 305(3), 1163-1172.
36. Lipscomb, J. C., Fisher, J. W., Confer, P. D., and Byczkowski, J. Z. (1998). In vitro to in vivo extrapolation for trichloroethylene metabolism in humans. Toxicol. Appl. Pharmacol. 152(2), 376-387.
37. Marshall, E. K., and Owens, A. H. (1954). Absorption, excretion and metabolic fate of chloral hydrate and trichloroethanol. Bull. Johns Hopkins Hosp. 95(1), 1-18.
38. Monster, A. C., Boersma, G., and Duba, W. C. (1976). Kinetics of trichloroethylene in volunteers; influence of work load and exposure concentration. Int. Arch. Occup. Environ. Health 38, 87-102.
39. Monster, A. C., Boersma, G., and Duba, W. C. (1979). Kinetics of trichloroethylene in repeated exposure of volunteers. Int. Arch. Occup. Environ. Health 42, 283-292.
40. Opdam, J. J. (1989a). Respiratory input in inhalation experiments. Br J. Ind. Med. 46(3), 145-156.
41. Opdam, J. J. (1989b). Intra and interindividual variability in the kinetics of a poorly and highly metabolising solvent. Br. J. Ind. Med. 46(12), 831-845.
42. Paykoc, Z. V., and Powell, J. F. (1945). The excretion of sodium trichloroacetate. J. Pharmacol. Exp. Ther. 85, 289-293.
43. Prout, M. S., Provan, W. M., and Green, T. (1985). Species differences in response to trichloroethylene. I. Pharmacokinetics in rats and mice. Toxicol. Appl. Pharmacol. 79(3), 389-400.
44. Sato, A., and Nakajima, T. (1979). A structure-activity relationship of some chlorinated hydrocarbons. Arch. Environ. Health 34(2), 69-75.
45. Sato, A., Nakajima, T., Fujiwara, Y., and Murayama, N. (1977). A pharmacokinetic model to study the excretion of trichloroethylene and its metabolites after an inhalation exposure. Br. J. Ind. Med. 34(1), 56-63.
46. Soucek, B., and Vlachova, D. (1960). Excretion of trichloroethylene metabolites in human urine 1. Br. J. Ind. Med. 17, 60-64.
47. U.S. Environmental Protection Agency (U.S. EPA). (2006). Use of Physiologically Based Pharmacokinetic Models to Quantify the Impact of Human Age and Interindividual Differences in Physiology and Biochemistry Pertinent to Risk (Final Report). Office of Research and Development, Washington, DC.
48. Völkel, W., Friedewald, M., Lederer, E., Pähler, A., Parker, J., and Dekant, W. (1998). Biotransformation of perchlorethene: Dose-dependent excretion of trichloroacetic acid, dichloroacetic acid, and N-acetyl-S-(trichlorovinyl)-L-cysteine in rats and humans after inhalation. Toxicol. Appl. Pharmacol. 153, 20-27.